original ) (raw )T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
Paula Bickford
Journal of Neuroinflammation, 2020
View PDFchevron_right
Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
Sara Raquel Ferreira
Frontiers in cellular neuroscience, 2018
View PDFchevron_right
The relation between α-synuclein and microglia in Parkinson’s Disease: Recent developments
Marina Romero-ramos
Neuroscience, 2015
View PDFchevron_right
Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity
Vanesa Sanchez-guajardo , Marina Romero-ramos
ASN NEURO, 2013
View PDFchevron_right
Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
Steven Pierce
Molecular Neurodegeneration, 2019
View PDFchevron_right
MHCII Is Required for -Synuclein-Induced Activation of Microglia, CD4 T Cell Proliferation, and Dopaminergic Neurodegeneration
Randy Cron
Journal of Neuroscience, 2013
View PDFchevron_right
Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease
Kent Fitzgerald
PLoS ONE, 2013
View PDFchevron_right
Etude de l'implication des cellules microgliales et de l'α-synucleine dans la maladie neurodégénérative de Parkinson
Henning Draheim
View PDFchevron_right
Increased immune activation by pathologic alpha‐synuclein in Parkinson's Disease
Karin Danzer
Annals of Neurology
View PDFchevron_right
Microglia Mediated Neuroinflammation in Parkinson’s Disease
sevim isik
Cells
View PDFchevron_right
The influence of microglia on the pathogenesis of Parkinson's disease
Caitriona Long-Smith
Progress in Neurobiology, 2009
View PDFchevron_right
α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease
Marina Romero-ramos
Biomedicines
View PDFchevron_right
Role of Microglia in Parkinson
Dima Obari
2014
View PDFchevron_right
Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity
Simone Bido
Nature Communications
View PDFchevron_right
Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease
Sarah Doss
Experimental Neurology, 2012
View PDFchevron_right
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
Marina Romero-ramos
Neurobiology of disease, 2017
View PDFchevron_right
Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson’s Disease?
Elzbieta Janda
Frontiers in Molecular Neuroscience
View PDFchevron_right
In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease
Chiara Cerami
Parkinsonism & Related Disorders, 2013
View PDFchevron_right
Glial Innate Immunity Generated by Non-Aggregated Alpha-Synuclein in Mouse: Differences between Wild-type and Parkinson's Disease-Linked Mutants
Mario Delgado
PLoS ONE, 2010
View PDFchevron_right
Periphery and brain, innate and adaptive immunity in Parkinson’s disease
Marina Romero-ramos
Acta Neuropathologica
View PDFchevron_right
The A53T mutation in α-synuclein enhances pro-inflammatory activation in human microglia
Rudolf Jaenisch
View PDFchevron_right
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of α-Synucleinopathies
Kazunari Sekiyama
Parkinson's disease, 2012
View PDFchevron_right
α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology
Daniel Otzen
Journal of Neuroinflammation, 2016
View PDFchevron_right
α-Synuclein induces migration of BV-2 microglial cells by up-regulation of CD44 and MT1-MMP
SEONGHAN KIM
Journal of Neurochemistry, 2009
View PDFchevron_right
Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein
w zhang
Glia, 2007
View PDFchevron_right
Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates
Vanesa Sanchez-guajardo , P. Barkholt , Marina Romero-ramos
Neuroscience, 2012
View PDFchevron_right
Physiology and Pathology of Neuroimmunology: Role of Inflammation in Parkinson’s Disease
Fermín Pacheco-Moisés
Physiology and Pathology of Immunology, 2017
View PDFchevron_right
Neuroinflammation in Parkinson's Disease and Related Disorders: A Lesson from Genetically Manipulated Mouse Models of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML"><mml:mi mathvariant="bold">α-Synucleinopathies
Kazunari Sekiyama
Parkinson's Disease, 2012
View PDFchevron_right
MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease
Anetta Wronska
Acta neurobiologiae experimentalis, 1999
View PDFchevron_right
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
Paul Lucassen
Progress in Neurobiology, 2012
View PDFchevron_right
Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide
George B Stefano
Medical science monitor : international medical journal of experimental and clinical research, 2002
View PDFchevron_right
Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease
Georgia Xiromerisiou
International Journal of Molecular Sciences
View PDFchevron_right